Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
GNI Hong Kong Ltd Insider Profile
4 Followers
GNI Hong Kong Ltd, Ten Percent Owner at Gyre Therapeutics, holds 0.00 shares in Gyre Therapeutics (Ticker: GYRE).
GNI Hong Kong Ltd has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
GNI Hong Kong Ltd does not currently own shares as a corporate insider.
A breakdown of GNI Hong Kong Ltd's holdings
Insider Roles
Ten Percent Owner
Roles that GNI Hong Kong Ltd holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by GNI Hong Kong Ltd
GNI Hong Kong Ltd's Trading History
List of latest transactions for each holding click on a transaction to see GNI Hong Kong Ltd's performance on stock
You May Also Like
GNI Hong Kong Ltd insider profile FAQ
What is the percentage of profitable transactions made by GNI Hong Kong Ltd?
The percentage of profitable transactions made by GNI Hong Kong Ltd is ―.
What is the average return per transaction made by GNI Hong Kong Ltd?
The average return per transaction made by GNI Hong Kong Ltd is ―.
What stocks does GNI Hong Kong Ltd hold?
GNI Hong Kong Ltd holds: GYRE stocks.
What was GNI Hong Kong Ltd’s latest transaction?
GNI Hong Kong Ltd latest transaction was an Uninformative Sell of ―.
What was GNI Hong Kong Ltd's most profitable transaction?
GNI Hong Kong Ltd’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is GNI Hong Kong Ltd's role in Gyre Therapeutics?
GNI Hong Kong Ltd's role in Gyre Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.